HENDERSON MICHAEL THOMAS is a corporate insider who has filed 36 SEC Form 4 transactions in the past 12 months across 0 companies. No open-market purchases were recorded; all transactions were sales or other dispositions. Insider activity is one signal among many — past performance does not guarantee future results.

HENDERSON MICHAEL THOMAS

CEO

Latest Insider Transactions

Showing 10 of 27 transactions (past 365 days)

APGE
CEO
Exercise Conversion
$0
3,000 shares @ $0.00
Filed 2026-04-20Trade 2026-04-16
Apogee Therapeutics, Inc.
APGE
CEO
Exercise Conversion
$68.6K
3,000 shares @ $22.86
Filed 2026-04-20Trade 2026-04-16
Apogee Therapeutics, Inc.
APGE
CEO
Sale
$1.5M
17,800 shares @ $82.48
Filed 2026-04-11Trade 2026-04-08
Apogee Therapeutics, Inc.
APGE
CEO
Sale
$166.5K
2,000 shares @ $83.26
Filed 2026-04-11Trade 2026-04-08
Apogee Therapeutics, Inc.
APGE
CEO
Sale
$17K
200 shares @ $85.00
Filed 2026-04-11Trade 2026-04-08
Apogee Therapeutics, Inc.
APGE
CEO
Sale
$615K
8,219 shares @ $74.83
Filed 2026-03-14Trade 2026-03-11
Apogee Therapeutics, Inc.
APGE
CEO
Sale
$621.3K
8,363 shares @ $74.29
Filed 2026-03-14Trade 2026-03-11
Apogee Therapeutics, Inc.
APGE
CEO
Sale
$259.3K
3,418 shares @ $75.86
Filed 2026-03-14Trade 2026-03-11
Apogee Therapeutics, Inc.
APGE
CEO
Sale
$481.2K
7,551 shares @ $63.73
Filed 2026-02-14Trade 2026-02-11
Apogee Therapeutics, Inc.
APGE
CEO
Sale
$723.7K
11,494 shares @ $62.96
Filed 2026-02-14Trade 2026-02-11
Apogee Therapeutics, Inc.

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.